| Follow Us: | |
 |
|
| Recommend Us: |
Jaundice Management
Jaundice occurs in most newborn infants, and although most is benign, newborns must be monitored to identify those who might develop severe hyperbilirunemia and, in rare cases, acute bilirubin encephalopathy or kernicterus.
In the management of jaundice, the ability to screen easily and treat effectively is crucial to newborn health. It requires an approach that is:
- Noninvasive
- Simple to use
- Both efficient and effective
Phototherapy can help deliver all of these attributes. Below are resource materials about jaundice management.
Resources
Research Papers
- Management of Hyperbilirubinemia in the Newborn Infant >35 Weeks of Gestation
In July 2004, the Subcommittee on Hyperbilirubinemia of the American Academy of Pediatrics (AAP) published its clinical practice guideline on the management of hyperbilirubinemia in the newborn infant 35 weeks of gestation, and a similar guideline was published in 2007 by the Canadian Paediatric Society.
- Transcutaneous Bilirubin Levels in the First 96 Hours - Maisels
To obtain transcutaneous bilirubin (TcB) measurements, at 6-hour intervals, in the first 96 hours after birth in a normal newborn population (gestational age: > or =35 weeks).
- Evaluation of a New Transcutaneous Bilirubinometer_Maisels et al
The objective of this study was to evaluate the Minolta/Hill-Rom Air-Shields Transcutaneous Jaundice Meter model JM-103. We studied a convenience sample of 849 newborns > or =35 weeks of gestation in 3 hospitals.
- Transcutaneous Bilirubinometers and Ethnicity
We read with interest De Luca et al’s comparison of the Medick BiliMed and Respironics BiliChek transcutaneous bilirubinometers. We agree that BiliChek provides a reliable measure of skin bilirubin and it performed well in our ethnically diverse population.